Kyowa Hakko Kirin Begins Japan, S. Korea Trials For New Aranesp Indication
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin has initiated trails in Japan and South Korea for its darbepoetin, which it developed with Amgen for treating anemia associated with kidney disorders.